The Law & Health Care Program: Making an Impact
Expanding health insurance to uncovered populations. Physician-assisted suicide. The use of genetic information. Racial and ethnic disparities in access to health care. These and other issues are among the most complex and controversial in our society today.
A pioneer in health care law, the Law and Health Care Program (L&HCP) combines education and research on emerging medical, health policy and legal matters, addressing health law issues from both legal and interdisciplinary perspectives, and capitalizes on access to the state and federal government. Ranked #3 in U.S. News & World Report's survey of the nation's best law school specialty programs, the L&HCP continues to meet the growing demand for lawyers and policy makers capable of addressing this increasingly complex field.
Maryland health care providers who work with patients and families at the end-of-life assembled April 2 at UM Carey Law for a day-long training session on how to use the new MOLST form for medical orders directing resuscitation and other life-sustaining measures. The Maryland Health Care Ethics Committee Network (MHECN), an initiative of the Law & Health Care Program, sponsored the session. The MOLST form, proposed in 2011 and replacing the Maryland DNR form, includes medical orders regarding resuscitation status as well as other life sustaining treatments. The proposed regulations were recently updated to extend the date until July 1, 2013 for when assisted living programs, home health agencies, hospices, kidney dialysis centers, nursing homes, and hospitals (for certain patients) must complete MOLST forms for newly admitted patients. The workshop was designed for health care providers who interact with patients and families regarding end-of-life decision making. Attendees learned how to use the Maryland MOLST form and their obligations and requirements under the MOLST regulations. Professor Diane Hoffmann, director of the Law & Health Care Program, worked with MHECN Coordinator Dr. Anita Tarzian to organize the program. Dr. Patricia Tomsko Nay, medical director, Maryland Office of Health Care Quality, and Paul Ballard, assistant attorney general, led the training session.
The Law & Health Care Program, in conjunction with the University of Maryland School of Pharmacy’s Center for Drugs and Public Policy and Arnold & Porter LLP, will host a day-long conference, entitled Emerging Issues in Food and Drug Law: Implementation of FDASIA, on Wednesday, April 17. The Food and Drug Administration Safety and Innovation Act (FDASIA), signed into law on July 9, 2012, gives the FDA the authority to collect user fees from industry to fund reviews of innovator drugs, medical devices, generic drugs, and biosimilar biologics. It also reauthorizes two programs that encourage pediatric drug development. A number of Law & Health Care Program alums, along with important FDA officials will speak at the conference, including: Keynote Speaker Leslie Kux, JD, assistant commissioner for Policy, FDA; Melissa B. Burns, acting director for Guidance, Office of Device Evaluation, Center for Devices and Radiological Health, FDA; and Laura R. Brosch, PhD, RN, director, Human Research Protections Office, U.S. Army Medical Material Command. The conference, which will be held at Arnold & Porter’s Washington, DC office, is free but registration is required.